Dr. Victoria Gomez, Assistant Professor of Medicine, Gastroenterologist and Interventional Endoscopist at the Mayo Clinic in Florida, discusses weight loss therapy with the ORBERA™ intragastric balloon.

FDA approved in August 2015, ORBERA™ is a silicone balloon that is placed in the stomach endoscopically and left in in the stomach for six months, and assists patients with losing weight, when combined with lifestyle intervention and integration in a weight loss program.
The Mayo Clinic in Florida is now offering ORBERATM for those patients that qualify for this type of weight loss therapy.

свернуть